Alpha 2.0
Login Register
» Authors » B Maillere

B Maillere

Explore the profile of B Maillere including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 520
Followers 0
Related Specialties
Allergy & Immunology
Molecular Biology
Pathology
Top 10 Co-Authors
A Menez
M Herve
C Texier
G Mourier
J Cotton
S Leroy
M Leonetti
M Busson
M Pallardy
D Charron
Published In
Mol Immunol
J Immunol Methods
Clin Exp Allergy
Clin Exp Immunol
J Immunol
Affiliations
Soon will be listed here.
Recent Articles
1.
Identification of T-cell epitopes from benzylpenicillin conjugated to human serum albumin and implication in penicillin allergy
Azoury M, Fili L, Bechara R, Scornet N, de Chaisemartin L, Weaver R, et al.
Allergy . 2018 Jan; 73(8):1662-1672. PMID: 29355985
Background: There is in vitro evidence that T cells from allergic patients react to benzylpenicillin-human serum albumin (BP-HSA) bioconjugates. Our group has recently shown the existence of naïve CD4 T...
2.
T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses
Reynolds C, Suleyman O, Ortega-Prieto A, Skelton J, Bonnesoeur P, Blohm A, et al.
Sci Rep . 2018 Jan; 8(1):672. PMID: 29330423
Zika virus (ZIKV) Infection has several outcomes from asymptomatic exposure to rash, conjunctivitis, Guillain-Barré syndrome or congenital Zika syndrome. Analysis of ZIKV immunity is confounded by the fact that several...
3.
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, et al.
Clin Exp Immunol . 2015 May; 181(3):385-400. PMID: 25959571
Biopharmaceuticals (BPs) represent a rapidly growing class of approved and investigational drug therapies that is contributing significantly to advancing treatment in multiple disease areas, including inflammatory and autoimmune diseases, genetic...
4.
In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene
Pashov A, Calvez T, Gilardin L, Maillere B, Repesse Y, Oldenburg J, et al.
Haemophilia . 2013 Oct; 20(2):176-84. PMID: 24118514
Forty per cent of haemophilia A (HA) patients have missense mutations in the F8 gene. Yet, all patients with identical mutations are not at the same risk of developing factor...
5.
Identification and frequency of circulating CD4(+) T lymphocytes specific to Benzylpenicillin in healthy donors
Nhim C, Delluc S, Halgand F, de Chaisemartin L, Weaver R, Claude N, et al.
Allergy . 2013 Jun; 68(7):899-905. PMID: 23751122
Background: Drug hypersensitivity is known to rely on a drug-specific T-cell response. Amplitude of antigen-specific T-cell response is partly controlled by the size of the antigen-specific naïve CD4(+) T-cell repertoire,...
6.
A simple competitive assay to determine peptide affinity for HLA class II molecules: a useful tool for epitope prediction
Bernardeau K, Kerzhero J, Fortun A, Moreau-Aubry A, Favry E, Echasserieau K, et al.
J Immunol Methods . 2011 Jul; 371(1-2):97-105. PMID: 21729700
We have designed a cytometry-based competition assay to evaluate peptide binding to empty recombinant HLA class II molecules. The efficiency of this assay was evaluated using recombinant HLA-DP0401 molecules (HLA-DP)...
7.
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
Tartour E, Pere H, Maillere B, Terme M, Merillon N, Taieb J, et al.
Cancer Metastasis Rev . 2011 Jan; 30(1):83-95. PMID: 21249423
The immune system regulates angiogenesis in cancer with both pro- and antiangiogenic activities. The induction of angiogenesis is mediated by tumor-associated macrophages and myeloid-derived suppressor cells (MDSC) which produce proinflammatory...
8.
Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses
Wambre E, Bonvalet M, Bodo V, Maillere B, Leclert G, Moussu H, et al.
Clin Exp Allergy . 2010 Nov; 41(2):192-203. PMID: 21105918
Background: A better understanding of allergen-specific CD4(+) T cell responses is needed to help improving immunological therapies. Objective To compare CD4(+) T cell responses against seasonal (Bet v 1) and...
9.
Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy
Chabre H, Gouyon B, Huet A, Baron-Bodo V, Boran-Bodo V, Nony E, et al.
Clin Exp Allergy . 2009 Nov; 40(3):505-19. PMID: 19895591
Background: Differences between major allergens from distinct grass species remain to be investigated, both in terms of structure and antigenicity. Methods: Group 1 and 5 allergens purified from five common...
10.
Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins
Bourgault Villada I, Moyal Barracco M, Berville S, Bafounta M, Longvert C, Premel V, et al.
Clin Exp Immunol . 2009 Oct; 159(1):45-56. PMID: 19843089
Cell-mediated immunity directed against human papillomavirus 16 (HPV-16) antigens was studied in 16 patients affected with classic vulvar intra-epithelial neoplasia (VIN), also known as bowenoid papulosis (BP). Ten patients had...